Article info
PDFHepatology
Original article
Efficacy and safety of sofosbuvir plus simeprevir therapy in Egyptian patients with chronic hepatitis C: a real-world experience
- Correspondence to Dr Yasser Mahrous Fouad, Gastroenterology and Endemic Medicine, Endemic Medicine Department, Faculty of Medicine, Minia University, Minia 19111, Egypt; yasserfouad10{at}yahoo.com
Citation
Efficacy and safety of sofosbuvir plus simeprevir therapy in Egyptian patients with chronic hepatitis C: a real-world experience
Publication history
- Received April 7, 2016
- Accepted July 14, 2016
- First published August 10, 2016.
Online issue publication
December 13, 2017
Article Versions
- Previous version (9 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/